APERTURA GENE THERAPY - Trademark Details
Status: 641 - Non-Final Action - Mailed
Image for trademark with serial number 90803113
Serial Number
90803113
Word Mark
APERTURA GENE THERAPY
Status
641 - Non-Final Action - Mailed
Status Date
2022-01-11
Filing Date
2021-06-30
Mark Drawing
4000 - Standard character mark Typeset
Law Office Assigned Location Code
L10
Employee Name
CAYCEDO, CATHERINE ANN
Statements
Goods and Services
Research and development in the field of gene therapy for the treatment of human and animal disease
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
P - Partially Paid
Class Status Date
2022-01-11
Primary Code
042
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
J. DICKSON PHILLIPS, III
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0117968
Original Filing Date USPTO
2022-01-06
International Registration Number
1643340
International Registration Date
2022-01-06
International Status Code
480
International Renewal Date
2032-01-06
Madrid History Events
DateCodeDescription
2022-01-06NEWAPNEW APPLICATION FOR IR RECEIVED
2022-01-06ACERTAUTOMATICALLY CERTIFIED
2022-01-06APPSTIR CERTIFIED AND SENT TO IB
2022-02-11CREATAPPLICATION FOR IR REGISTERED BY IB
Trademark Events
Event DateEvent Description
2021-07-03NEW APPLICATION ENTERED IN TRAM
2021-09-12NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2021-12-22ASSIGNED TO EXAMINER
2022-01-11REMOVED FROM TEAS PLUS
2022-01-11NON-FINAL ACTION WRITTEN
2022-01-11NON-FINAL ACTION E-MAILED
2022-01-11NOTIFICATION OF NON-FINAL ACTION E-MAILED